Skip to main content

Kymera Therapeutics, Inc 10-K for FY2022

Kymera Therapeutics, Inc. (KYMR)

10-K 2023-02-23 For: 2022-12-31
View Original
Added on April 10, 2026

About this 10-K

Kymera Therapeutics, Inc filed this 10-K on February 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$46.83M
down 35.7% from $72.83M a year earlier
Net loss
$154.81M
compared with a net loss of $100.22M a year earlier
Diluted EPS
-$2.87
compared with -$2.09 a year earlier